Literature DB >> 21749835

A case study: neuroleptic malignant syndrome with risperidone and CYP2D6 gene variation.

Shinichiro Ochi1, Koichiro Kawasoe, Masao Abe, Ryuji Fukuhara, Kantaro Sonobe, Kentaro Kawabe, Shu-ichi Ueno.   

Abstract

We present a schizophrenic patient who experienced neuroleptic malignant syndrome with risperidone treatment due to variants of the CYP2D6 gene with reduced function. Clinicians need to be aware of this potential complication. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21749835     DOI： 10.1016/j.genhosppsych.2011.03.003

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN： 0163-8343            Impact factor:   3.238


  2 in total

1.  Two cases of neuroleptic malignant syndrome in elderly patients taking atypical antipsychotics.

Authors:  Yuhui Feng; Xianhong Yang; Yanyan Huang
Journal:  Shanghai Arch Psychiatry       Date:  2013-06

Review 2.  Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis.

Authors:  Martino Belvederi Murri; Argentina Guaglianone; Michele Bugliani; Pietro Calcagno; Matteo Respino; Gianluca Serafini; Marco Innamorati; Maurizio Pompili; Mario Amore
Journal:  Drugs R D       Date:  2015-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.